(firstQuint)A Safety and Tolerability Study of UBX0101 in Patients With Osteoarthritis of the Knee.

 This study is a phase 1, randomized, double-blind, placebo-controlled single ascending dose study that will evaluate safety, tolerability, and pharmacokinetics of UBX0101 in patients diagnosed with painful femoro-tibial osteoarthritis.

 Patients will be randomly allocated to receive UBX0101 or placebo in 3:1 randomization by dose level (cohort).

 The primary objective is to establish the safety and tolerability of UBX0101 given as a single intra-articular injection into the femoro-tibial joint of patients with osteoarthritis.

.

 A Safety and Tolerability Study of UBX0101 in Patients With Osteoarthritis of the Knee@highlight

A study to evaluate safety, tolerability, and pharmacokinetics of a single intra-articular injection of UBX0101 in patients diagnosed with painful osteoarthritis of the knee.

